Evidence map›Paper›PMID 33233397›Full record

ArticleMolecules (Basel, Switzerland)2020

(

Hee Jin Jung, Sang Gyun Noh, Il Young Ryu, Chaeun Park, Ji Young Lee, Pusoon Chun, Hyung Ryong Moon, Hae Young Chung

Open access · goldAbstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.1field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 18 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Heterocyclic Compounds as Synthetic Tyrosinase Inhibitors: Recent Advances.International journal of molecular sciences · 2023
    Review
  6. Article
  7. Design and Synthesis of (Antioxidants (Basel, Switzerland) · 2022
    Article
  8. Article
  9. Article
  10. Novel Anti-Melanogenic Compounds, (Molecules (Basel, Switzerland) · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Hee Jin JungCollege of Pharmacy, Pusan National University, Busan 46241, Korea.
Sang Gyun NohCollege of Pharmacy, Pusan National University, Busan 46241, Korea.
Il Young RyuCollege of Pharmacy, Pusan National University, Busan 46241, Korea.
Chaeun ParkCollege of Pharmacy, Pusan National University, Busan 46241, Korea.
Ji Young LeeCollege of Pharmacy, Pusan National University, Busan 46241, Korea.
Pusoon ChunCollege of Pharmacy and Inje Institute of Pharmaceutical Sciences and Research, Inje University, Gimhae, Gyeongnam 50834, Korea.
Hyung Ryong MoonCollege of Pharmacy, Pusan National University, Busan 46241, Korea.ORCID 0000-0003-1119-7112
Hae Young ChungCollege of Pharmacy, Pusan National University, Busan 46241, Korea.ORCID 0000-0002-3215-8828
Pusan National University · KRInje University · KR

Funding

National Research Foundation of Korea 2018R1A6A3A11047399
6 · The paper itself

Abstract

A series of (

Indexed as

Computer SimulationAgaricalesAnimalsBinding SitesCell SurvivalEnzyme InhibitorsFuransInhibitory Concentration 50KineticsMelaninsMelanoma, ExperimentalMiceMolecular Docking SimulationMolecular Dynamics SimulationMonophenol MonooxygenaseEnzyme InhibitorsFuransMelaninsMonophenol Monooxygenasefuran-chalconemelanogenesismolecular dynamicstyrosinase inhibitor

Identifiers

PMID33233397
PMCPMC7700175
OpenAlexW3107778052

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.